Lyterian Therapeutics
H‑1B Sponsor Verified
Yes. Lyterian Therapeutics filed 8 H-1B labor condition applications (LCAs) with the U.S. Department of Labor from 2023–2025, including 1 in 2025. The average H-1B salary is $171,307 and the most sponsored role is Executive Director, Early Lead Chemistry.
Source: U.S. Department of Labor LCA disclosure data. Most recent filing on record: Jan 30, 2025.
LinkedIn ↗Latest Year Filings
1
In 2025
↗ Filter by year
Total H‑1B Filings
8
Since 2020
↗ View records
Avg Annual Salary
$171,307
All years combined
↗ View chart
Top Role
Executive Director, Early Lead Che…
↗ Click to filter
Filing trend
H‑1B filings by year for Lyterian Therapeutics
| Year | LCA filings | Avg salary |
|---|---|---|
| 2025 | 1 | $166,000 |
| 2024 | 4 | $164,200 |
| 2023 | 3 | $182,553 |
Click a bar to filter records
Yearly filings & average salary · swipe to explore
SponsorStats AI
Summary